Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by inthnoon Nov 25, 2022 6:29pm
189 Views
Post# 35129307

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Momentum forward

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Momentum forward
westcoast, I think you should know me better than this as when I post information it is always with the quotes from either the pr or whatever report it was from. All I was asking is to have the quotes or information where it said 3-4 analysts all say that we should have a partnership early 2023. That was not an unreasonable request. I and everyone already know we have analysts following the company as it is on the onc website. That is not the question that I asked. And everyone should not be considered suspect just because they ask a question that they do not have the information for. That is the purpose of the boards to help and inform others which you, myself, note , canadafan and many others have done.
<< Previous
Bullboard Posts
Next >>